Skip to content
PubMed This is a summary of 19 peer-reviewed journal articles Updated
Metabolic Medicine

The Pillars of Care: Nitisinone and the Metabolic Diet

At a Glance

Nitisinone (NTBC) and a strict low-protein diet are the primary, lifelong treatments for Tyrosinemia Type 1 (HT1). Nitisinone stops the production of dangerous toxins, while the metabolic diet prevents the buildup of tyrosine, protecting the liver, kidneys, and eyes.

Managing Tyrosinemia Type 1 (HT1) requires a dedicated, lifelong commitment to two main treatments that work in tandem: a medication called nitisinone and a specialized low-protein diet. Together, these have transformed HT1 from a life-threatening illness into a manageable chronic condition [1][2].

Nitisinone (NTBC): The Vital Blockade

Before the discovery of nitisinone (NTBC), the body would break down protein until it reached the “broken” part of the assembly line, creating the toxin succinylacetone [2].

Nitisinone works by moving the “blockade” further up the line. It inhibits an enzyme called 4-HPPD, which is several steps before the toxic build-up happens [3][4]. By stopping the process earlier, nitisinone prevents the production of the toxins that cause liver cancer, liver failure, and kidney damage [2][5].

Administration of Nitisinone

Nitisinone is taken by mouth and is available in capsules or as a liquid suspension [3]. For infants and small children, capsules can be opened and mixed into a small amount of water, medical formula, or applesauce to make it easier to take. Your medical team will instruct you on the correct dosage and administration method based on your child’s weight and age [2].

The Importance of Adherence

Nitisinone has a long half-life, meaning it stays in the body for a while [3]. A single slightly delayed dose will not instantly cause a severe crisis. However, consistent adherence is critical. If medication is repeatedly missed or discontinued over time, the body will begin producing toxins again [6]. Over days or weeks, this can trigger a neurovisceral crisis—a severe medical emergency characterized by extreme abdominal pain, vomiting, high blood pressure, and nerve issues like weakness or seizures [6][7][8]. If you realize you have missed a dose, contact your metabolic team for instructions rather than panicking.

Sick Day Protocols

When a child with a metabolic disorder gets a common illness like a stomach bug, it can quickly become serious if they vomit their medication or refuse their medical formula [6]. You must have a clear “Sick Day Protocol” from your care team. If your child cannot keep their medication down or is not getting enough calories, you may need to go to the emergency room for intravenous (IV) fluids and medical support to prevent their body from breaking down its own muscle for energy (a state called catabolism) [2].

The Medical Diet: Managing the Side Effect

While nitisinone stops the toxins, it causes the “raw material” (tyrosine) to back up in the blood [9][3]. This is known as secondary hypertyrosinemia.

If tyrosine levels get too high (typically above 400–500 µmol/L), it can cause harmful side effects, most notably corneal crystals (keratopathy) [10][11]. Photophobia (extreme sensitivity to light) is an early warning sign. If you notice your child squinting, tearing up constantly, or trying to avoid bright lights, contact your team immediately [9][12].

To prevent this, children must follow a protein-restricted diet [13]:

  1. Low-Protein Foods: Natural protein (found in meat, dairy, beans, and nuts) must be strictly limited because it contains tyrosine and phenylalanine (which the body turns into tyrosine) [14][15].
  2. Medical Formula: To ensure your child gets enough protein for growth without the harmful amino acids, they must drink a specialized metabolic formula that is tyrosine-free and phenylalanine-free [16].

Interestingly, because the diet is so restrictive, some children’s phenylalanine levels may drop too low, which can also cause growth issues. In these cases, the dietitian may prescribe a specific phenylalanine supplement [15].

When is Liver Transplantation Needed?

While nitisinone and diet are the gold standard, there are rare cases where a liver transplant is necessary [17]:

  • Late Diagnosis: If the liver was already severely damaged or developed cancer (HCC) before treatment started [2][18].
  • Non-Response: In very rare instances where a child does not respond well to medical therapy or cannot tolerate the treatment [17].
  • Suspicious Growths: If imaging shows nodules in the liver that the medical team suspects could be cancerous despite treatment [2].

A transplant “cures” the liver disease because the new liver has the working FAH enzyme, but it is a major surgery with its own lifelong requirements, so medical management is always the first choice [19].

Common questions in this guide

Why do children with Tyrosinemia Type 1 need to take nitisinone?
Nitisinone blocks a specific enzyme in the body to stop the production of harmful toxins that cause severe liver and kidney damage. It is a critical, lifelong medication that transformed HT1 into a manageable condition.
Why is a low-protein diet necessary when taking nitisinone?
While nitisinone stops dangerous toxins, it causes the amino acid tyrosine to build up in the blood. A strict low-protein diet, along with special medical formula, prevents tyrosine levels from getting too high and causing side effects like eye damage.
What are the signs that my child's tyrosine levels are too high?
High tyrosine levels can cause corneal crystals to form in the eyes. An early warning sign of this is extreme sensitivity to light, known as photophobia. If your child is squinting, constantly tearing up, or avoiding bright lights, contact your doctor immediately.
What should I do if my child misses a dose of nitisinone or gets sick?
It is essential to have a specific sick day protocol from your metabolic team. If your child misses doses or cannot keep their medication down due to vomiting, you may need to go to the emergency room for IV fluids and medical support to prevent a severe metabolic crisis.
Will my child ever need a liver transplant for HT1?
Most patients do very well on nitisinone and a metabolic diet. However, a liver transplant may be needed in rare cases if the liver was already severely damaged before treatment began, if liver cancer is suspected, or if the medical therapy is not tolerated.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What are the specific target blood levels for tyrosine and nitisinone that we are aiming for?
  2. 2.How often should we check my child's blood levels, and what is the process for adjusting the dose as they grow?
  3. 3.What is the exact 'emergency protocol' if my child vomits their medication or becomes too ill to eat?
  4. 4.Can you recommend a metabolic dietitian who can help us plan a low-protein menu and choose the right medical formula?
  5. 5.How often do we need to see an ophthalmologist to check for corneal crystals?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (19)
  1. 1

    Long-Term Outcomes and Practical Considerations in the Pharmacological Management of Tyrosinemia Type 1.

    van Ginkel WG, Rodenburg IL, Harding CO, et al.

    Paediatric drugs 2019; (21(6)):413-426 doi:10.1007/s40272-019-00364-4.

    PMID: 31667718
  2. 2

    Phenotype, genotype, and outcome of 25 Palestinian patients with hereditary tyrosinemia type 1.

    Dweikat I, Qawasmi N, Najeeb A, Radwan M

    Metabolism open 2021; (9()):100083 doi:10.1016/j.metop.2021.100083.

    PMID: 33598652
  3. 3

    The Discovery of the Mode of Action of Nitisinone.

    Lock EA

    Metabolites 2022; (12(10)) doi:10.3390/metabo12100902.

    PMID: 36295804
  4. 4

    From Weed Killer to Wonder Drug.

    Lock EA

    Advances in experimental medicine and biology 2017; (959()):175-185 doi:10.1007/978-3-319-55780-9_16.

    PMID: 28755195
  5. 5

    Evaluation of dynamic thiol/disulfide homeostasis in hereditary tyrosinemia type 1 patients.

    Aktuglu Zeybek AC, Kiykim E, Neselioglu S, et al.

    Pediatric research 2022; (92(2)):474-479 doi:10.1038/s41390-021-01770-6.

    PMID: 34628487
  6. 6

    SIADH as an Underrecognized Manifestation of Porphyria-like Crises in Hereditary Tyrosinemia Type 1: Clinical and Pathophysiological Insights.

    Saraceno E, Serra I, Bracci B, et al.

    International journal of molecular sciences 2026; (27(2)) doi:10.3390/ijms27020660.

    PMID: 41596311
  7. 7

    Severe neurological crisis in adult patients with Tyrosinemia type 1.

    Dawson C, Ramachandran R, Safdar S, et al.

    Annals of clinical and translational neurology 2020; (7(9)):1732-1737 doi:10.1002/acn3.51160.

    PMID: 32820610
  8. 8

    A Case Report of a Very Rare Association of Tyrosinemia type I and Pancreatitis Mimicking Neurologic Crisis of Tyrosinemia Type I.

    Uçar HK, Tümgör G, Kör D, et al.

    Balkan medical journal 2016; (33(3)):370-2 doi:10.5152/balkanmedj.2016.141074.

    PMID: 27308087
  9. 9

    Nitisinone-Induced Keratopathy in Alkaptonuria: A Challenging Diagnosis Despite Clinical Suspicion.

    White A, C Tchan M

    JIMD reports 2018; (40()):7-9 doi:10.1007/8904_2017_56.

    PMID: 28879639
  10. 10

    Efficacy of low dose nitisinone in the management of alkaptonuria.

    Sloboda N, Wiedemann A, Merten M, et al.

    Molecular genetics and metabolism 2019; (127(3)):184-190 doi:10.1016/j.ymgme.2019.06.006.

    PMID: 31235217
  11. 11

    Nitisinone causes acquired tyrosinosis in alkaptonuria.

    Khedr M, Cooper MS, Hughes AT, et al.

    Journal of inherited metabolic disease 2020; (43(5)):1014-1023 doi:10.1002/jimd.12229.

    PMID: 32083330
  12. 12

    Asymptomatic Corneal Keratopathy Secondary to Hypertyrosinaemia Following Low Dose Nitisinone and a Literature Review of Tyrosine Keratopathy in Alkaptonuria.

    Khedr M, Judd S, Briggs MC, et al.

    JIMD reports 2018; (40()):31-37 doi:10.1007/8904_2017_62.

    PMID: 28942493
  13. 13

    Dietary restriction of tyrosine and phenylalanine lowers tyrosinemia associated with nitisinone therapy of alkaptonuria.

    Hughes JH, Wilson PJM, Sutherland H, et al.

    Journal of inherited metabolic disease 2020; (43(2)):259-268 doi:10.1002/jimd.12172.

    PMID: 31503358
  14. 14

    Emotional and behavioral problems, quality of life and metabolic control in NTBC-treated Tyrosinemia type 1 patients.

    van Vliet K, van Ginkel WG, Jahja R, et al.

    Orphanet journal of rare diseases 2019; (14(1)):285 doi:10.1186/s13023-019-1259-2.

    PMID: 31801588
  15. 15

    Long-term cognitive functioning in individuals with tyrosinemia type 1 treated with nitisinone and protein-restricted diet.

    García MI, de la Parra A, Arias C, et al.

    Molecular genetics and metabolism reports 2017; (11()):12-16 doi:10.1016/j.ymgmr.2017.01.016.

    PMID: 28377889
  16. 16

    Hereditary tyrosinemia type Ⅰ: newborn screening, diagnosis and treatment.

    Tang Y, Kong Y

    Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences 2021; (50(4)):514-523 doi:10.3724/zdxbyxb-2021-0255.

    PMID: 34704422
  17. 17

    Live donor liver transplantation for type 1 tyrosinemia: An analysis of 15 patients.

    Karaca CA, Yilmaz C, Farajov R, et al.

    Pediatric transplantation 2019; (23(6)):e13498 doi:10.1111/petr.13498.

    PMID: 31155831
  18. 18

    Hereditary Tyrosinemia Type 1 Mice under Continuous Nitisinone Treatment Display Remnants of an Uncorrected Liver Disease Phenotype.

    Neuckermans J, Lequeue S, Claes P, et al.

    Genes 2023; (14(3)) doi:10.3390/genes14030693.

    PMID: 36980965
  19. 19

    Liver Transplantation for Tyrosinemia Type 1 in the Developing World: Is It Really the Best We Can Offer?

    Bolia R, Srivastava A

    Indian journal of pediatrics 2022; (89(5)):427-428 doi:10.1007/s12098-022-04128-w.

    PMID: 35262865

This page provides educational information about Tyrosinemia Type 1 treatments and diet. It is not a substitute for professional medical advice from your pediatric metabolic team.

Get notified when new evidence is published on Tyrosinemia type 1.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.